To determine the prevalence of giardiasis in Gambian children with chronic diarrhoea and to assess their response to treatment, 31 children with chronic diarrhoea and malnutrition were investigated for giardiasis using a combination of serology (specific antigiardia IgM antibody) and microscopy of faeces and jejunal biopsy specimens. Fourteen of 31 children with chronic diarrhoea had giardiasis compared with only four of 33 healthy age and sex matched control children. Four of 15 malnourished children without diarrhoea were giardia positive. Twenty three children with chronic diarrhoea were reinvestigated after treatment with metronidazole; giardia was found in 11 of them. These results show that giardia is highly prevalent in children with chronic diarrhoea and malnutrition and that the infection does not respond to standard therapeutic measures.
Infection with Giardia lamblia is a recognised cause of chronic diarrhoea and malabsorption in children and may be associated with growth retardation.1 2 High prevalence rates for giardia infection have been reported in children in developing countries even if they are asymptomatic. 1 Diagnosis of giardiasis is usually based on microscopic identification of either trophozoites or cysts in faeces, but this method is unreliable and may miss many cases.5 6 Diagnostic precision can be improved by microscopic examination of duodenal aspirate,6 endoscopic brushings,7 or intestinal mucosa. 8 To circumvent these invasive techniques, serological methods have been developed. 9 Giardia infection leads to a prolonged specific antigiardia IgG response that lasts for many weeks or months; it is therefore unreliable in the diagnosis of the acute infection. Specific antigiardia IgM, however, is a much better indicator of acute infection. We have developed a serum antigiardia IgM enzyme linked immunosorbent assay (ELISA) as a diagnostic test for giardiasis with a sensitivity and specificity of 96%.9 Giardiasis can persist for many months in children who are malnourished and immunocompromised. There have, however, been no prospective studies of the impact of nutritional rehabilitation on the response to treatment of giardiasis in children with protein energy malnutrition.
The aims of this study were to find out the prevalence of giardiasis in a group of children with chronic diarrhoea and malnutrition in The Gambia, West Africa, and to assess the response to antigiardial treatment in children being treated for chronic diarrhoea and malnutrition.
Subjects and methods
The study was undertaken at the Medical Research Council's station in The Gambia, West Africa in children aged 6 to 36 months with chronic diarrhoea-malnutrition syndrome. This is defined as more than three loose stools/ day persisting for more than two weeks and severe protein energy malnutrition (defined as weight for height of <75% of the National Center for Health Statistics median value). These patients (table 1) were recruited from the outpatient department and compared with age and sex matched control subjects comprising a group of well grown asymptomatic children (healthy controls) and a further group of children with protein energy malnutrition but with no history of diarrhoea (marasmic controls). Control subjects were recruited from the same geographical location as the patients with diarrhoea. While they were inpatients, all children with chronic diarrhoea malnutrition syndrome received empirical treatment with chloramphenicol 75-200 mg/kg/day and metronidazole 25 mg/kg/day for seven days.
Giardia trophozoites and cysts were sought by wet film microscopy of three consecutive fresh stool specimens (without concentration) collected before any treatment was started. There is evidence that this technique will detect giardia as reliably as concentrates.'0 In addition to standard stool microscopy, antigiardia IgM titres were determined by an ELISA and a specific antigiardia IgM antibody titre of 1:800 or more was taken to indicate active giardia infection.9 The third diagnostic procedure in children with chronic diarrhoea malnutrition Although the dose of metronidazole that we used was that recommended for children, it is possible that more effective clearance of the organism might have occurred had a higher dose (for example, 35 mg/kg/day) been given for 10 days. The value of primary eradication of giardia in children with chronic diarrhoea needs to be assessed as does the value of a repeat course of treatment after nutritional rehabilita-tion and restoration of normal immune function.
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